Cargando…
Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients
BACKGROUND: One of the main causes of anaemia in patients with end-stage renal disease is relative deficiency in erythropoietin production. Eythropoiesis stimulating agent (ESA), a potent haematopoietic growth factor, is used to treat anaemia in haemodialysis patients. The effect of ESA is usually a...
Autores principales: | Hasegawa, Shun, Nakamura, Seishi, Sugiura, Tetsuro, Tsuka, Yoshiaki, Takahashi, Nobuyuki, Matsumura, Koichiro, Okumiya, Toshika, Baden, Masato, Shiojima, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666014/ https://www.ncbi.nlm.nih.gov/pubmed/34895154 http://dx.doi.org/10.1186/s12882-021-02623-4 |
Ejemplares similares
-
Diagnostic accuracy and clinical usefulness of erythrocyte creatine content to predict the improvement of anaemia in patients receiving maintenance haemodialysis
por: Hayashi, Ohki, et al.
Publicado: (2023) -
Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study
por: Matsumura, Koichiro, et al.
Publicado: (2020) -
A novel method for calculating mean erythrocyte age using erythrocyte creatine
por: Kameyama, Masashi, et al.
Publicado: (2020) -
Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023) -
Erythrocytes and Erythropoietin
por: Föller, Michael, et al.
Publicado: (2011)